The best job perk is self-determination.
The reputation of all COVID-19 vaccines hinges on improving perceptions of the Johnson & Johnson shot.
A long-COVID patient and an immunologist help us understand the mysterious condition.
Here’s how to find out if your workplace’s return-to-office plans are actually safe.
Months of exuberant hand-sanitizing and social isolation during the pandemic have changed our exposure to microbes, in ways good and bad.
The internet has decided that Pfizer is significantly cooler than Moderna—but why?
“One country’s crisis is every country’s crisis.”
Readjusting our ideas about what’s safe is going to take time.
Headaches, eye pain, nausea—her symptoms began last spring. No one knows exactly why, except that the pandemic is to blame.
What if a single vaccine could protect us against SARS, MERS, COVID-19, and every other coronavirus-related disease, forever and ever?
The rules need to change after vaccination. But carefully.
Antibodies are great and all, but macrophages, B cells, and helper T cells deserve some attention too.
The notion that lockdowns increased the rate of death by suicide last year has become common knowledge. It’s not backed up by data.
We still don’t know who’s most at risk of getting the Johnson & Johnson vaccine blood clots.
So are theories to explain it.
What the “pause” in Johnson & Johnson vaccinations means
Being so close (and yet so far) is a stress all its own.
Some people’s bodies aren’t set up for vaccines.
Concerns about blood clots with Johnson & Johnson underscore just how lucky Americans are to have the Pfizer and Moderna shots.
Public-health leaders in rural America are turning toward the next and more difficult stage of the nationwide vaccination campaign: persuasion.